A new candidate vaccine against hepatitis E, developed collaboratively by GlaxoSmithKline (GSK) and the Walter Reed Army Institute of Research (WRAIR), was found to be 95.5% effective in a Phase Two trial, according to a study to be published in the New England Journal of Medicine.
The Indian Government has proposed to increase the allocation for the National Rural Health Mission (NRHM) from Rs.8,207 crore in 2006-07 to Rs.9,947 crore in 2007-08.
A new vaccine delivery system using microspheres of a biodegradable polymer may not only reduce the need for booster shots in some cases, but also appears to stimulate an immune response that traditional vaccines do not.
A new report from the World Health Organization (WHO) shows that neurological disorders, ranging from epilepsy to Alzheimer disease, from stroke to headache, affect up to one billion people worldwide.
“Nanotechnology has the potential to generate enormous health benefits for the more than five billion people living in the developing world,” according to Dr. Peter A. Singer, senior scientist at the McLaughlin-Rotman Centre for Global Health and Professor of Medicine at University of Toronto.
African scientists will soon begin training at Emory University as part of a unique partnership between Emory and the Republic of South Africa. The South Africa Drug Discovery Training Program will address the rising dangers of diseases that unduly affect developing countries.
The Cricket World Cup (Cup) will be held in several Caribbean nations (Jamaica, St Kitts & Nevis, Antigua & Barbuda, St Lucia, St Vincent & Grenadines, Barbados, Grenada, Trinidad & Tobago, and Guyana) March 4?April 28, 2007.
A new mathematical approach applied to 121 human populations infected with malaria revises the basic reproductive number — an indication of the transmission intensity — up by an order of magnitude, with serious implications for effective malaria control.
Merck & Co., Inc. announced that it has begun to file registrations for ATRIPLA? (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), a once-daily, single tablet regimen for the treatment of HIV-1 infection in adults, with health authorities in those developing countries around the world where many HIV-positive people live.
Scientific studies of why foods such as Brussels sprouts and stout beer are horribly bitter-tasting to some people but palatable to others are shedding light on a number of questions, from the mechanisms of natural selection to understanding how our genes affect our dietary habits.